HCC-827-PIK3CA-M, PC-9-PIK3CA-M, H1975 and H1650 cells were treated with BYL719 and Gefitinib, and expression levels of PIK3CA, p-AKT were measured at 24 h. The gene discussed is AKT1; the disease is hepatocellular carcinoma.